Literature DB >> 23503819

Myocardial perfusion imaging and cardiac involvement in the indeterminate phase of Chagas disease.

Amalia Peix1, Raymid García, Jesús Sánchez, Lázaro O Cabrera, Kenia Padrón, Oscar Vedia, Hugo V Choque, Jorge Fraga, Juan Bandera, Alberto Hernández-Cañero.   

Abstract

BACKGROUND: Myocardial perfusion imaging (MPI) has been used in the assessment of chagasic heart disease.
OBJECTIVE: To investigate the value of gated-single photon emission computed tomography (gated-SPECT) MPI to detect early cardiac involvement in chagasic patients in the indeterminate phase, who present segmental motion abnormalities detected by tissue Doppler imaging (TDI)-derived strain.
METHODS: Forty individuals (mean age: 25±2 years, 50% males) from an endemic area of Chagas disease and with positive serologic diagnosis, were included. All underwent gated-SPECT two-day (stress-rest) MPI and echocardiography.
RESULTS: Thirty individuals (75%) showed a normal scan. In three cases (8%) the MPI was slightly abnormal, and in seven it was equivocal. In all cases with reversible defects, the affected segments were coincident with those with motion abnormalities. A post-stress left ventricular ejection fraction (LVEF) reduction > 5% (ΔLVEF < -5%) was found in 11 out of 40 individuals (28%). Both the phase-derived standard deviation and the histogram bandwidth showed a significant difference between post-stress and rest. In both cases there was a slight dyssynchrony at rest which normalized at post-stress.
CONCLUSIONS: A stress-rest gated-SPECT is a valid approach to detect early myocardial alterations, as well as intraventricular dyssynchrony in the indeterminate phase of Chagas disease in patients with segmental motion abnormalities previously detected by TDI-derived strain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503819     DOI: 10.5935/abc.20130023

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  5 in total

1.  The long way to defeating Chagas cardiomyopathy.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

2.  Chagas heart disease: A contemporary review.

Authors:  Alejandro Velasco; Carlos A Morillo
Journal:  J Nucl Cardiol       Date:  2018-07-18       Impact factor: 5.952

3.  The Indeterminate Form of Chagas Disease.

Authors:  Victor Sarli Issa
Journal:  Arq Bras Cardiol       Date:  2018-02       Impact factor: 2.000

4.  Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study.

Authors:  Rafael Brolio Pavão; Henrique Turin Moreira; Antonio Oswaldo Pintya; Jorge Luis Haddad; André Vannuchi Badran; Moysés de Oliveira Lima-Filho; Igor Matos Lago; João Reynaldo Abbud Chierice; André Schmidt; J Antonio Marin-Neto
Journal:  Rev Soc Bras Med Trop       Date:  2021-11-12       Impact factor: 1.581

Review 5.  New Imaging Parameters to Predict Sudden Cardiac Death in Chagas Disease.

Authors:  Renata J Moll-Bernardes; Paulo Henrique Rosado-de-Castro; Gabriel Cordeiro Camargo; Fernanda Souza Nogueira Sardinha Mendes; Adriana S X Brito; Andréa Silvestre Sousa
Journal:  Trop Med Infect Dis       Date:  2020-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.